MET and breast carcinoma: Not only is the function of HGF affected by TSP-1, the expression of this anti-angiogenic factor has also been shown to be down-regulated by HGF-c-Met interactions in breast cancer cells [41], indicating a negative regulatory circuit of TSP1 and HGF.